Chestnut Poised for Revival, Thanks to Transgenic Work

The American chestnut, decimated by a fungus that scientists have tried in vain to quell throughout this century, finally may be on its way back to health, thanks largely to genetics. Once a dominant tree throughout the Northeast, prized for the timber from its long, unbranched trunks, the American variety (Castanea dentata) stopped providing those famed chestnuts roasting on an open fire long before Bing Crosby's time. The tree bore sweet nuts, but they were small, and the quest for a meatier n

Written bySteve Bunk
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Once a dominant tree throughout the Northeast, prized for the timber from its long, unbranched trunks, the American variety (Castanea dentata) stopped providing those famed chestnuts roasting on an open fire long before Bing Crosby's time. The tree bore sweet nuts, but they were small, and the quest for a meatier nut led to the species's downfall. Such notables as Thomas Jefferson in the 18th century and Luther Burbank in the 19th century imported European and Asian chestnut varieties. By 1904, the fungus Cryphonectria parasitica was identified in New York City, and the blight had begun.

Thought to have come from Japan, the fungus causes cankers that disrupt nutrient movement and eventually girdle the stem. By midcentury, mature natives were virtually wiped out, although multiple stems often still could sprout from the roots and grow until the fungus struck again. This cycle of sprouting, early death, and resprouting relegated the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies